Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by TheRock07on Nov 17, 2016 9:04am
548 Views
Post# 25473892

RE:RE:RE:RE:If it breaks 9.70 ...

RE:RE:RE:RE:If it breaks 9.70 ...Having been a former shareholder of Paladin, and with the same management and game plan with applied GUD and executing in the same but acceleerated manner, this is my largest investment by far.

Abundant cash, no debt, high quality investments that can be cherry picked and a highly diversified drug pipeline that is not dependent on one or two super drugs and no R & D, GUD reamins a compelling buy.

If your time frame is not that of a momentum trader, GUD is perhaps amongst the top 5 % on the TSX.

I add a few thousand on any pullbacks, as cash becomes available.

These are my views and why I have a large investment here..
Bullboard Posts